U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07761455) titled 'Prophylactic IABP in Delayed-Presentation Anterior STEMI' on Aug. 01.

Brief Summary: PROACTIVE-AMI is a prospective, multicenter, randomized, open-label trial with blinded endpoint adjudication evaluating whether prophylactic intra-aortic balloon counterpulsation (IABP) initiated before primary percutaneous coronary intervention (PPCI) improves clinical outcomes in patients with delayed-presentation acute anterior ST-segment elevation myocardial infarction (STEMI). Eligible patients are adults aged >=18 years who present 4 to 12 hours after symptom onset, have electrocardiographic evidence of anterior STEMI with proximal left anteri...